What Proneem does

Proneem is a French biotechnology company founded in 2002 and headquartered in Marseille that develops and commercializes microencapsulation-based treatments for the textile industry. Its core technology embeds naturally derived active ingredients (initially Neem oil, now a broader biosourced palette) inside micrometric membranes that are fixed into textile fibers and release their functional payload progressively through friction. The portfolio spans three lines: PROTECT (biocidal solutions such as the anti-dust mite PRONEEM®, the vector-control PROTECTOR® co-developed with MERCK, the bed-bug-repellent BLOCK BEDBUGS®, and the bio-based PRONEEM BIOACTIVE®), TECHNIC (COOL'IN®, THERMO™, DRY PROTECT® for thermal and moisture performance), and WELLNESS (PURE®, Relax CBD®, RESPIRE® for sensory and aromatherapy functions). The proprietary NOVA™ fully biodegradable microcapsule platform, developed in-house, is positioned as the next-generation chemistry layer.

The firm operates a dual revenue model: B2B licensing of its microencapsulation technologies to textile manufacturers who apply the treatments by padding or spraying during finishing, and private-label commercialization of finished consumer products through major retailers (notably CARREFOUR and LA REDOUTE in France) plus direct-to-consumer specialty items such as Block Bedbugs spray and Viral Stop masks. Customers are primarily manufacturers and brands serving bedding and home textiles, sports and outdoor apparel, medical and healthcare textiles, outdoor/vector-control equipment, and cosmetics/wellness applications. PRONEEM® holds a Marketing Authorization from the European Commission — described as the only such authorization held by an anti-dust mite textile treatment in the bedding sector — providing a regulatory moat reinforced by Oeko-Tex Standard 100 certification and BPR 528/2012 compliance.

Proneem reinvests approximately 22% of annual revenue into R&D through an in-house laboratory (integrated since 2013) and, in 2023, opened a 1,400 m² Industry 4.0 facility in Marseille. The company is privately held under the legal entity Yellow Pony (a sole proprietorship registered in Paris) and is led by CEO Nathalie Hagege. It expanded internationally in 2021 with a subsidiary in South Korea and has received European Regional Development Fund (FEDER) co-funding for the development of NOVA™ and the ABSoluTEX antibacterial project. No external institutional investment, public listing, or AI/ML capabilities are disclosed in available sources.

Name

Proneem

Legal name

Yellow Pony

Website

https://proneem.com

Company type

Private

Founded year

2002

Operating status

Operating

Headcount range

11–50 employees

Short description

Proneem is a French biotechnology company that develops microencapsulation-based textile treatments, licensing biosourced anti-dust mite, insect-repellent, antibacterial, thermal, and wellness technologies to textile manufacturers, brands, and private-label retailers globally.

Ownership category

akta.pro rank

Product category

Specialty Chemicals / Biotechnology

NAICS

Plastics Material and Resin Manufacturing (325211)

SIC

Industrial Organic Chemicals (2860)

akta.pro primary industry

Biodegradable Additives & Masterbatches (pro-oxidant-free, bio-based modifiers) (IMAEAOAD)

akta.pro secondary industries

Compostable Materials & Certified Compostables (IMAEAOAC), Microbiome Manufacturing, Formulation & Delivery Technologies (encapsulation, spores, oral delivery) (HLAAAFAJ)

Keywords

• Textile microencapsulation
• Antimicrobial textile treatments
• Bio-based textile chemistry
• Insect repellent fabrics
• Cosmetic textile finishes

Headquarters

HQ city

Marseille

HQ country

France

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales, Others

Revenue model

1. Technology Licensing to Textile Manufacturers: Proneem licenses its microencapsulation technologies and treatments to textile manufacturers and brands. Manufacturers apply Proneem's technologies during textile finishing processes (padding or spraying) and pay for the technology/treatment solutions.
2. Private Label Products: Development and commercialization of finished consumer products under private label arrangements. Proneem has entered private label collections at major retailers (CARREFOUR, LA REDOUTE) and developed finished products like Block Bedbugs spray and Viral Stop masks/sprays.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

Proneem develops and licenses microencapsulation-based bioactive treatments that embed naturally derived actives (essential oils, antimicrobials, repellents, cosmetic ingredients) into textile fibers for controlled, durable release. The company monetizes this know-how by licensing proprietary technologies to textile manufacturers and brands, and by producing finished products via private-label partnerships with major retailers across bedding, apparel, and home-textile categories.

Product overview

Proneem offers a portfolio of microencapsulation-based textile treatment technologies organized into three product lines: PROTECT (biocidal solutions: PRONEEM®, PROTECTOR®, BLOCK BEDBUGS®, PRONEEM BIOACTIVE®), TECHNIC (performance solutions: COOL'IN®, THERMO™, DRY PROTECT®), and WELLNESS (comfort solutions: PURE®, Relax CBD®, RESPIRE®). All technologies use patented microencapsulation to embed natural active ingredients into textile fibers for controlled, long-lasting release. The core platform is the proprietary microencapsulation technology, with the NOVA™ biodegradable microcapsule platform representing the latest generation.

Differentiator

Problem solved

Functional benefit

Brands

• PRONEEM: Anti-dust mite textile treatment technology based on natural Neem oil microencapsulation.
• PROTECTOR
• BLOCK BEDBUGS
• PRONEEM BIOACTIVE
• COOL'IN
• THERMO
• DRY PROTECT
• PURE
• Relax CBD
• RESPIRE
• VIRAL STOP
• NOVA

Products and services

• PRONEEM® anti-dust-mite technology Microencapsulated natural active treatment applied to textiles (bedding, mattresses, home textiles) to provide durable, wash-resistant protection against dust mites. Sold/licensed to textile manufacturers and consumer-textile brands.
• PROTECTOR® anti-vector repellent

Quantifiable outcome

• PRONEEM® achieves 100% dust mite mortality rate with effectiveness maintained after 20 washes
• +6 more outcomes

Named customers2 records

Segments5 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Three partnerships are on record, tiered minor and core.

• Marseille Soap Factory (Usine de Savon de Marseille)minorStrategic or Co-development Partner · 1 January 2009Partnership to develop ECO-DUVET®, combining Proneem's anti-dust mite technology with Marseille soap expertise for innovative bedding products.
• OlnicacoreTechnology or Integration · 1 January 2009Partnership with Olnica for the creation and implementation of the DNA Textile® traceability and control system, enabling full product traceability from raw materials to end consumers.
• MERCK GroupcoreStrategic or Co-development PartnerPROTECTOR® was developed in collaboration with the MERCK Group. The solution combines MERCK's IR3535 molecule with Proneem's microencapsulation technology and vegetable-based Eucalyptus Citriodora oil, creating a high-performance vector control treatment certified safe by WHO.

Scale indicators5 records

Recent moves8 records

Expansion highlights6 records

Broad incumbents

• Archroma: Global specialty chemicals incumbent (owned by SK Capital) supplying the full textile value chain with finishing, coating, and functional chemistries. While not microencapsulation-focused, it serves the same bedding and apparel customers as Proneem with broader portfolios.
• CHT Group: Major German textile auxiliaries and specialty chemicals supplier offering silicone, fluorocarbon, and functional finishes for apparel and home textiles. Competes with Proneem's TECHNIC range as a broad incumbent.
• Tanatex Chemicals (now Pulcra Chemicals): Dutch-based textile finishing chemicals supplier with broad enzymatic and functional treatment lines. Overlaps with Proneem's range of bio-based and performance finishes across European accounts.
• Rudolf Group: German family-owned textile chemistry specialist with strong positions in functional finishes, including antimicrobial and cooling treatments. Serves Proneem's same European B2B customer base at greater scale.

Direct peers

• HeiQ Materials AG: Swiss specialty textile chemistry company offering branded antimicrobial, cooling, and performance finishes (e.g., HeiQ Smart Temp, HeiQ Allergen Tech). Closest comparable in size, B2B licensing model, and functional-finish positioning to Proneem's PROTECT/TECHNIC ranges.
• Polygiene Group AB: Swedish antimicrobial/odor-control technology supplier to apparel and home textile brands. Overlaps with Proneem's PRONEEM BIOACTIVE® antibacterial and DRY PROTECT® anti-odor ranges in B2B licensing and brand partnerships.
• Sciessent LLC: US-based provider of antimicrobial and anti-odor textile technologies (Agion, SciCryl). Competes directly with Proneem BIOACTIVE® and Vector Guard-style applications in B2B textile chemistry licensing.
• Devan Chemicals: Belgian specialty chemical firm whose Purissimo® and microencapsulation-based product lines directly compete with Proneem's PROTECTOR and PURE offerings in textile finishing and fragrance/aromatherapy applications.

Emerging players

• Evolved By Nature: US biotech/textile company building Activated Silk™ bio-based textile chemistries. Comparably positioned as a smaller, bio-based chemistry challenger to incumbents, with similar sustainable-textile positioning to Proneem's NOVA platform.
• Life Materials: Specialist microencapsulation company whose NaturGuard and sustainable encapsulation ranges overlap with Proneem's core microencapsulation technology and biodegradable capsule platform.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/proneem
• Facebookfr-fr.facebook.com/proneem
• LinkedInlinkedin.com/company/proneem

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Proneem